Search
for
Sort by
Research 31–60 of 60
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Dermatological Indications: Alopecia Areata
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing Alopecia
- Successful management of severe alopecia areata and vitiligo using topical delgocitinib and a 308-nm excimer laser
- Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting
- Mechanism of PPARα agonist in alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- The Role of Janus Kinase Inhibitors in Dermatology
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Alopecia Areata: Current Treatments and New Directions
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Alopecia areata – Current understanding and management
- Immune therapies for alopecia areata: evidence and new perspectives
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia areata – Aktuelles Verständnis und Management
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Efficacy and Safety of Fractional CO2 Laser Combined with Halometasone Cream for Treatment of Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized Trial
- Alopecia Areata in Latin America: Where are We and Where are We Going?
- SnapshotDx Quiz: April 2022